{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:59:51Z","timestamp":1767866391531,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.atherosclerosis.2007.03.002","type":"journal-article","created":{"date-parts":[[2007,4,7]],"date-time":"2007-04-07T11:16:30Z","timestamp":1175944590000},"page":"958-965","source":"Crossref","is-referenced-by-count":33,"title":["The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome"],"prefix":"10.1016","volume":"196","author":[{"given":"Christina","family":"Charitidou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Farmakiotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki","family":"Zournatzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ifigenia","family":"Pidonia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodosia","family":"Pegiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Karamanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Hatzistilianou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilias","family":"Katsikis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Panidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2217\/17455057.2.4.561","article-title":"Update on polycystic ovary syndrome","volume":"2","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Women's Health"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.fertnstert.2005.02.017","article-title":"Luteneizing hormone levels are markedly increased and significantly correlated with \u03944-androstenedione levels in lean women with polycystic ovary syndrome","volume":"84","author":"Panidis","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0015-0282(98)00512-3","article-title":"Polymorphism TC (\u221234bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome","volume":"71","author":"Diamanti-Kandarakis","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib4","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diabetes.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in the polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib5","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1210\/jc.82.12.4075","article-title":"Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens","volume":"82","author":"Nestler","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","article-title":"A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome","volume":"72","author":"Nestler","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based prospective population study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2005.10.007","article-title":"Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives","volume":"185","author":"Cussons","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib9","first-page":"1353","article-title":"Cardiovascular risk in adolescent and young adult obese females with PCOS","volume":"5","author":"Macut","year":"2001","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib11","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","author":"Paradisi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib12","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/jc.2004-0751","article-title":"Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation","volume":"89","author":"Tarkun","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib13","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/jc.87.2.742","article-title":"Altered vascular function in young women with polycystic ovary syndrome","volume":"87","author":"Kelly","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib14","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1210\/jc.86.10.4666","article-title":"Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy","volume":"86","author":"Diamanti-Kandarakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib16","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2003-031867","article-title":"Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib17","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1210\/jc.2005-0151","article-title":"Predictors of endothelial dysfunction in young women with polycystic ovary syndrome","volume":"90","author":"Kravariti","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of NO synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0008-6363(03)00500-5","article-title":"The emerging role of ADMA as a novel cardiovascular risk factor","volume":"59","author":"B\u00f6ger","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib20","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","article-title":"Risk of acute coronary events and serum concentrations of asymmetric dimethylarginine","volume":"358","author":"Valkonen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib21","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.0000126823.07732.D5","article-title":"Assymetrical dimethylarginine. The \u0170ber Marker?","volume":"109","author":"Cooke","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib22","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1515\/CCLM.2005.196","article-title":"Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality","volume":"43","author":"B\u00f6ger","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib23","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00125-002-0975-6","article-title":"Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?","volume":"45","author":"Chan","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome PCOS","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2362.2006.01712.x","article-title":"Inflammatory and endothelial markers in women with polycystic ovary syndrome","volume":"36","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1172\/JCI116604","article-title":"Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia","volume":"92","author":"Kourembanas","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib27","doi-asserted-by":"crossref","first-page":"241S","DOI":"10.1042\/CS103S241S","article-title":"Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure","volume":"103","author":"Ohnishi","year":"2002","journal-title":"Clin Sci"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1191\/1358863x06vm636oa","article-title":"Plasma markers of NO synthase activity in women after ovarian hyperstimulation: influence of estradiol on ADMA","volume":"11","author":"Cevic","year":"2006","journal-title":"Vasc Med"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib29","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1161\/01.CIR.0000091083.61609.DF","article-title":"Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine","volume":"108","author":"Holden","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib30","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1210\/jc.2003-030584","article-title":"Effect of hormone replacement therapy on plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early post-menopausal women","volume":"88","author":"Post","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/01.fjc.0000192149.83008.dc","article-title":"Estrogen replacement effectively improves the accelerated intimal hyperplasia following ballon injury of carotid artery in the ovariectomized rats","volume":"47","author":"Ishibahshi","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0002-9378(98)70437-5","article-title":"Plasma concentration of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia","volume":"178","author":"Holden","year":"1998","journal-title":"Am J Obst Gynecol"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib33","first-page":"H853","article-title":"17\u03b2-Estradiol reduces vasoconstriction in endothelium-denuded rat aortas through inducible NOS","volume":"43","author":"Binco","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jb\/117.2.237","article-title":"Detection of NG,NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody","volume":"117","author":"Kimoto","year":"1995","journal-title":"J Biochem (Tokyo)"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib35","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1161\/01.CIR.99.24.3092","article-title":"Novel mechanism for endothelial dysfunction. Dysregulation of dimethylarginine dimethylaminohydrolase","volume":"99","author":"Ito","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/eje.0.1500215","article-title":"Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjuction with peroral cyproterone acetate in women with polycystic ovary syndrome","volume":"150","author":"Vrb\u03afkov\u00e1","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2005.07.1306","article-title":"Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome","volume":"85","author":"Mastorakos","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib38","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationships between insulin resistance and endothelial dysfunction. Molecular and pathophysiological mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.03.002_bib39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1043-2760(02)00612-4","article-title":"The role of lifestyle modification in polycystic ovary syndrome","volume":"13","author":"Norman","year":"2002","journal-title":"Trends Endocrinol Metab"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007001657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007001657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T10:54:26Z","timestamp":1546944866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915007001657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0021915007001657"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.03.002","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}